Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response

  1. Salzano, M.
  2. Vázquez-Cedeira, M.
  3. Sanz-García, M.
  4. Valbuena, A.
  5. Blanco, S.
  6. Fernández, I.F.
  7. Lazo, P.A.
Aldizkaria:
Oncotarget

ISSN: 1949-2553

Argitalpen urtea: 2014

Alea: 5

Zenbakia: 7

Orrialdeak: 1770-1778

Mota: Artikulua

DOI: 10.18632/ONCOTARGET.1678 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus